Immunomodulatory drugs: temporary pregnancy prevention guidance during coronavirus (COVID-19), MHRA
The MHRA has agreed to temporary modifications to be made to the pregnancy prevention programmes for these medicines to facilitate home pregnancy testing and remote consultations, where clinically appropriate, during the COVID-19 pandemic.
The novel coronavirus (SARS-CoV-2) that arose in China in December 2019 resulted in an epidemic that quickly expanded with particular intensity in the United States and European countries, particularly Italy and Spain, devastating the foundations of our nations in one of the most significant public health threats of our time. Sadly, this disease has spread globally, and from March 12 on, the American Society for Reproductive Medicine and European Society of Human Reproduction and Embryology made similarly cautious recommendations on managing patients who were undergoing infertility therapy or desiring pregnancy, but withou...
Conclusion: There are several anesthetic considerations in the care of pregnant women with COVID-19 due to their unique physiological changes. We provide considerations and recommendations for departmental and institutional leadership as well as the obstetric anesthesia providers. These recommendations may apply and can be edited, for future droplet or airborne based pandemics. The rapidly evolving literature makes it important to get updates directly from the relevant medical societies' websites.
The global pandemic of SARS-CoV-2, the cause of Coronavirus disease 2019 (COVID-19), has been associated with worse outcomes in several patient populations, including the elderly and those with chronic comorbidities. Data from previous pandemics and seasonal influenza suggest that pregnant women may be at increased risk for infection-associated morbidity and mortality. Physiological changes in normal pregnancy and metabolic and vascular changes of high-risk pregnancies may affect pathogenesis or exacerbate the clinical presentation of COVID-19.
New and expecting moms are facing pandemic-related fears on top of social isolation.
Guidance has been published to support initiation of valproate in female patients and for annual review and pregnancy testing during the coronavirus pandemic.
At least 54 percent of sexually active adolescent women in Kenya who would like to postpone pregnancy have an unmet need for modern contraception. Credit: Miriam Gathigah/IPSBy Miriam GathigahNAIROBI, May 25 2020 (IPS) It was only when 17-year-old Eva Muigai was in her final trimester that her family discovered she was pregnant. Muigai, a form three student who lives with her family in Gachie, Central Kenya, had spent her pregnancy wearing tight bodysuits and loose-fitting clothes that hid her growing baby bump. “The plan was to have an abortion but I was too scared. My classmate had an abortion last year and she alm...
AbstractIntroductionPrenatal maternal distress has a negative impact on the course of pregnancy, fetal development, offspring development and later psychopathologies. The study aimed to determine the extent to which the Coronavirus disease 2019 (COVID ‐19) pandemic may aggravate pregnant women prenatal distress and psychiatric symptomatology.Material and methodsTwo cohorts of pregnant volunteer women were evaluated, one that was recruited before the COVID ‐19 pandemic (n=496) through advertisements in prenatal clinics in Quebec, Canada, from April 2018 to March 2020; the other (n=1258) was recruited online during the p...
ConclusionsMost of the pregnant COVID ‐19 positive patients had a favorable clinical course. However, one‐third of them developed pneumonia, of whom 5% presented a critical clinical status. CRP and D‐dimer levels positively correlated with severe pneumonia and the neutrophil/lymphocyte ratio decreased as the patients improved clin ically. Seventy‐eight percent of patients had a vaginal delivery. No vertical or horizontal transmissions were diagnosed in the neonates during labor or breastfeeding.
Conclusions Among 92 women with confirmed or presumed COVID-19, the overall morbidity was low. These preliminary results are encouraging for pregnant women during the COVID-19 pandemic. Key Points [...] Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Article in Thieme eJournals: Table of contents | Abstract | Full text
Conclusion: Pregnant women residing in low resource countries represent a uniquely vulnerable group in epidemics due to several factors. Maternity services in low resource countries are adapting to provide antenatal and postnatal care amidst a rapidly shifting health system environment due to the COVID-19 pandemic. PMID: 32436744 [PubMed - as supplied by publisher]